US2007A
(en)
*
|
|
1841-03-16 |
|
Improvement in the mode of harvesting grain |
FR1356901A
(fr)
|
1958-03-13 |
1964-04-03 |
|
Nouveaux aminoétheroxydes, aminothioéthers et aminoesters dérivés du pyrrole, etleur procédé de préparation
|
US3168532A
(en)
|
1963-06-12 |
1965-02-02 |
Parke Davis & Co |
1, 5-diarylpyrrole-2-propionic acid compounds
|
US3168531A
(en)
|
1963-06-12 |
1965-02-02 |
Parke Davis & Co |
1-aryl-5-(p-lower alkoxyphenyl)-pyrrole-2-propionic acid compounds
|
US3285931A
(en)
|
1964-12-21 |
1966-11-15 |
Union Carbide Corp |
Preparation of substituted pyrrole derivatives
|
DE1938904U
(de)
|
1966-03-16 |
1966-05-18 |
Mondial G M B H |
Geraet mit einem hygrometer und einem thermometer zur beobachtung des wetterablaufes.
|
US3427305A
(en)
|
1966-11-01 |
1969-02-11 |
Searle & Co |
5 - ((halo/alkoxy)phenyl) - 1 - (p - sulfonamido(phenyl/benzyl)) - 2 - pyrrolepropionic acids
|
US3551571A
(en)
|
1967-05-19 |
1970-12-29 |
Endo Lab |
Methods for reducing pain,reducing fever and alleviating inflammatory syndromes with heteroaromatic pyrrol-3-yl ketones
|
GB1271082A
(en)
|
1968-05-07 |
1972-04-19 |
Wyeth John & Brother Ltd |
Furan, pyrrole and thiophene derivatives
|
FR2054474A2
(en)
|
1969-07-09 |
1971-04-23 |
Innothera Lab Sa |
Analgesic, antiinflammatory 1-phenyl-2, 5-di
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3714232A
(en)
|
1969-06-25 |
1973-01-30 |
Merck & Co Inc |
5-arylphenyl sulfonic acids
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
DE2419970C3
(de)
|
1974-04-25 |
1980-06-12 |
Hoechst Ag, 6000 Frankfurt |
3-<l-Pyrrolidinyl)-4-phenoxy-5sulfamoylbenzoesäure und Verfahren zu ihrer Herstellung
|
US4093735A
(en)
|
1974-04-25 |
1978-06-06 |
Hoechst Aktiengesellschaft |
5-Sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
CH628622A5
(de)
|
1976-12-24 |
1982-03-15 |
Ciba Geigy Ag |
Verfahren zur herstellung von neuen in 4-stellung substituierten 3-sulfamoylbenzoesaeuren.
|
US4335136A
(en)
|
1980-04-18 |
1982-06-15 |
E. I. Du Pont De Nemours And Company |
Anti-inflammatory 4,5-diaryl-α-(polyfluoroalkyl)-1H-pyrrole-2-methanamines
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
DE3309355A1
(de)
|
1983-03-16 |
1984-09-27 |
Basf Ag, 6700 Ludwigshafen |
Verfahren zur herstellung von pyrrolen
|
ES8702440A1
(es)
|
1984-10-04 |
1986-12-16 |
Monsanto Co |
Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa.
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US4694018A
(en)
|
1985-11-29 |
1987-09-15 |
G. D. Serale & Co. |
Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives
|
US4792568A
(en)
|
1986-04-14 |
1988-12-20 |
Rorer Pharmaceutical Corporation |
Aryl pyrroles as useful antiallergy compounds
|
NO881411L
(no)
|
1987-04-14 |
1988-10-17 |
Bayer Ag |
Substituerte pyrroler.
|
US5455263A
(en)
|
1987-07-29 |
1995-10-03 |
American Cyanamid Company |
Methods for the control and the protection of warm-blooded animals against infestation and infection by helminths, acarids and arthropod endo- and ectoparasites
|
US5010098A
(en)
|
1987-07-29 |
1991-04-23 |
American Cyanamid Company |
Arylpyrrole insecticidal acaricidal and nematicidal agents and methods for the preparation thereof
|
DE3727114A1
(de)
|
1987-08-14 |
1989-02-23 |
Basf Ag |
Verfahren zur herstellung von pyrrolen
|
CA1334975C
(en)
|
1987-11-13 |
1995-03-28 |
James H. Holms |
Furan and pyrrole containing lipoxygenase inhibiting compounds
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
US5612059A
(en)
|
1988-08-30 |
1997-03-18 |
Pfizer Inc. |
Use of asymmetric membranes in delivery devices
|
US5096919A
(en)
|
1989-01-05 |
1992-03-17 |
Ciba-Geigy Corporation |
Pyrrolylphenyl-substituted hydroxamic acid derivatives
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
US4962119A
(en)
|
1989-06-09 |
1990-10-09 |
Warner-Lambert Company |
Triazole derivatives of fenamates as antiinflammatory agents
|
CA2060309A1
(en)
|
1989-06-13 |
1990-12-14 |
Alison M. Badger |
Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
|
EP0479951A4
(en)
|
1989-06-26 |
1992-12-09 |
The Research Foundation Of State University Of New York |
Bis-acyloxymethyl derivatives
|
PH30995A
(en)
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
DD298912A5
(de)
|
1989-11-17 |
1992-03-19 |
�������@������������@��k�� |
Verfahren zur herstellung von 3-aminopyrrolen
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US5208018A
(en)
|
1990-03-19 |
1993-05-04 |
Brigham And Women's Hospital |
Treatment of cachexia with interleukin 2
|
IT1246382B
(it)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
DE4036706A1
(de)
|
1990-11-17 |
1992-05-21 |
Hoechst Ag |
Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
|
US5128485A
(en)
|
1990-12-17 |
1992-07-07 |
American Cyanamid Company |
Synthesis of 2-aryl-5-(trifluoromethyl)pyrroles useful as pesticidal agents and as intermediates for the preparation of said agents
|
US5144041A
(en)
|
1990-12-26 |
1992-09-01 |
American Cyanamid Company |
Process for the preparation of 2-aryl-1-substituted-5-(trifluoromethyl) pyrrole compounds useful as insecticidal, acaricidal and nematocidal agents and as intermediates for the manufacture of said agents
|
US5254713A
(en)
|
1991-04-09 |
1993-10-19 |
Nihon Bayer Agrochem K.K. |
2- and 3-chloropyrroles and process for preparing the same
|
JPH051027A
(ja)
|
1991-04-09 |
1993-01-08 |
Nippon Bayeragrochem Kk |
新規2−又は3−クロロピロール類及びその製造方法
|
YU8592A
(sh)
|
1991-08-28 |
1994-06-10 |
Flumroc Ag. |
Postupak i uređaj za izradu ploča od mineralnih vlakana primenjenih kao nosač zidnog premaza
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5928635A
(en)
|
1994-12-07 |
1999-07-27 |
Schmidt; Karlheinz |
Process for producing active agent complexes
|
JP3141261B2
(ja)
|
1992-10-22 |
2001-03-05 |
松下電工株式会社 |
警報表示器
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
US6274552B1
(en)
|
1993-03-18 |
2001-08-14 |
Cytimmune Sciences, Inc. |
Composition and method for delivery of biologically-active factors
|
US5523092A
(en)
|
1993-04-14 |
1996-06-04 |
Emory University |
Device for local drug delivery and methods for using the same
|
US5985307A
(en)
|
1993-04-14 |
1999-11-16 |
Emory University |
Device and method for non-occlusive localized drug delivery
|
US5380738A
(en)
|
1993-05-21 |
1995-01-10 |
Monsanto Company |
2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US5474995A
(en)
|
1993-06-24 |
1995-12-12 |
Merck Frosst Canada, Inc. |
Phenyl heterocycles as cox-2 inhibitors
|
US5593991A
(en)
|
1993-07-16 |
1997-01-14 |
Adams; Jerry L. |
Imidazole compounds, use and process of making
|
US6004534A
(en)
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
US5344991A
(en)
|
1993-10-29 |
1994-09-06 |
G.D. Searle & Co. |
1,2 diarylcyclopentenyl compounds for the treatment of inflammation
|
US5434178A
(en)
|
1993-11-30 |
1995-07-18 |
G.D. Searle & Co. |
1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
|
US5466823A
(en)
|
1993-11-30 |
1995-11-14 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides
|
US5418254A
(en)
|
1994-05-04 |
1995-05-23 |
G. D. Searle & Co. |
Substituted cyclopentadienyl compounds for the treatment of inflammation
|
US5496845A
(en)
|
1994-05-25 |
1996-03-05 |
American Cyanamid Co. |
Suspension concentrate compositions of arylpyrrole insecticidal and acaricidal agents
|
JP3302178B2
(ja)
|
1994-06-22 |
2002-07-15 |
日本クラウンコルク株式会社 |
合成樹脂製容器蓋
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
US5486534A
(en)
|
1994-07-21 |
1996-01-23 |
G. D. Searle & Co. |
3,4-substituted pyrazoles for the treatment of inflammation
|
US5616601A
(en)
|
1994-07-28 |
1997-04-01 |
Gd Searle & Co |
1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
|
US5620999A
(en)
|
1994-07-28 |
1997-04-15 |
Weier; Richard M. |
Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
|
US5759542A
(en)
|
1994-08-05 |
1998-06-02 |
New England Deaconess Hospital Corporation |
Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
|
US5521213A
(en)
|
1994-08-29 |
1996-05-28 |
Merck Frosst Canada, Inc. |
Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
|
GB2294879A
(en)
|
1994-10-19 |
1996-05-15 |
Merck & Co Inc |
Cylcooxygenase-2 Inhibitors
|
US5660854A
(en)
|
1994-11-28 |
1997-08-26 |
Haynes; Duncan H |
Drug releasing surgical implant or dressing material
|
JP2636819B2
(ja)
|
1994-12-20 |
1997-07-30 |
日本たばこ産業株式会社 |
オキサゾール系複素環式芳香族化合物
|
US5633272A
(en)
|
1995-02-13 |
1997-05-27 |
Talley; John J. |
Substituted isoxazoles for the treatment of inflammation
|
US5643933A
(en)
|
1995-06-02 |
1997-07-01 |
G. D. Searle & Co. |
Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US6316652B1
(en)
|
1995-06-06 |
2001-11-13 |
Kosta Steliou |
Drug mitochondrial targeting agents
|
US6136839A
(en)
|
1995-06-12 |
2000-10-24 |
G. D. Searle & Co. |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
|
US5700816A
(en)
|
1995-06-12 |
1997-12-23 |
Isakson; Peter C. |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
|
US5798119A
(en)
|
1995-06-13 |
1998-08-25 |
S. C. Johnson & Son, Inc. |
Osmotic-delivery devices having vapor-permeable coatings
|
AU6242096A
(en)
|
1995-06-27 |
1997-01-30 |
Takeda Chemical Industries Ltd. |
Method of producing sustained-release preparation
|
CA2180624C
(en)
|
1995-07-12 |
2006-12-12 |
Cheuk Kun Lau |
Diphenyl-1,2,3-thiadiazoles as anti-inflammatory agents
|
US5792778A
(en)
|
1995-08-10 |
1998-08-11 |
Merck & Co., Inc. |
2-substituted aryl pyrroles, compositions containing such compounds and methods of use
|
TW448055B
(en)
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
JP2909418B2
(ja)
|
1995-09-18 |
1999-06-23 |
株式会社資生堂 |
薬物の遅延放出型マイクロスフイア
|
US6039975A
(en)
|
1995-10-17 |
2000-03-21 |
Hoffman-La Roche Inc. |
Colon targeted delivery system
|
NZ322674A
(en)
|
1995-10-17 |
1999-08-30 |
Searle & Co |
Method of detecting cyclooxygenase-2
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
US6022886A
(en)
|
1996-02-01 |
2000-02-08 |
Smithkline Beecham Corporation |
Endothelin receptor antagonists
|
JPH09323930A
(ja)
|
1996-04-04 |
1997-12-16 |
Takeda Chem Ind Ltd |
悪液質の予防・治療剤
|
US5908858A
(en)
|
1996-04-05 |
1999-06-01 |
Sankyo Company, Limited |
1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
|
DK1288206T3
(da)
|
1996-04-12 |
2008-11-24 |
Searle Llc |
Substituerede benzensulfonamidderivater som prolægemidler af COX-2-inhibitorer
|
TW345603B
(en)
|
1996-05-29 |
1998-11-21 |
Gmundner Fertigteile Gmbh |
A noise control device for tracks
|
US6264970B1
(en)
|
1996-06-26 |
2001-07-24 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
CN1233954A
(zh)
|
1996-10-01 |
1999-11-03 |
西马实验室股份有限公司 |
掩盖味道的微胶囊组合物及其制备方法
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
ES2221019T3
(es)
|
1996-10-31 |
2004-12-16 |
Takeda Chemical Industries, Ltd. |
Preparacion de liberacion mantenida.
|
US6131570A
(en)
|
1998-06-30 |
2000-10-17 |
Aradigm Corporation |
Temperature controlling device for aerosol drug delivery
|
US5935990A
(en)
|
1996-12-10 |
1999-08-10 |
G.D. Searle & Co. |
Substituted pyrrolyl compounds for the treatment of inflammation
|
EP0946169B1
(en)
|
1996-12-20 |
2003-02-26 |
Takeda Chemical Industries, Ltd. |
Method of producing a sustained-release preparation
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
EP0863134A1
(en)
|
1997-03-07 |
1998-09-09 |
Merck Frosst Canada Inc. |
2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
US5972986A
(en)
|
1997-10-14 |
1999-10-26 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
|
US6025353A
(en)
|
1997-11-19 |
2000-02-15 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
|
JPH11246403A
(ja)
*
|
1997-12-24 |
1999-09-14 |
Sankyo Co Ltd |
腫瘍増殖の予防又は抑制剤
|
US6887893B1
(en)
*
|
1997-12-24 |
2005-05-03 |
Sankyo Company, Limited |
Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
|
JP3770450B2
(ja)
*
|
1998-01-28 |
2006-04-26 |
三共株式会社 |
癌転移抑制剤
|
US6350458B1
(en)
|
1998-02-10 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Mixed micellar drug deliver system and method of preparation
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
DE19812059C1
(de)
|
1998-03-19 |
1999-09-23 |
Wella Ag |
Diaminobenzol-Derivate sowie diese Diaminobenzol-Derivate enthaltende Haarfärbemittel
|
CA2262044C
(en)
|
1998-04-09 |
2001-10-30 |
Lucent Technologies Inc. |
Optimizing call-center performance by using predictive data to distribute agents among calls
|
US6048736A
(en)
|
1998-04-29 |
2000-04-11 |
Kosak; Kenneth M. |
Cyclodextrin polymers for carrying and releasing drugs
|
KR19990085365A
(ko)
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
US20040127470A1
(en)
*
|
1998-12-23 |
2004-07-01 |
Pharmacia Corporation |
Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist
|
US6649645B1
(en)
*
|
1998-12-23 |
2003-11-18 |
Pharmacia Corporation |
Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
|
US20040053900A1
(en)
|
1998-12-23 |
2004-03-18 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy
|
CA2357525A1
(en)
|
1999-01-27 |
2000-08-03 |
Cornell Research Foundation, Inc. |
Treating cancers associated with overexpression of her-2/neu
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
UA74803C2
(ru)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стойкий полиморф гидрохлорида n-(3-этинилфенил)-6,7-бис(2-метоксиэтокси)-4-хиназолинамина, способ его получения (варианты) и фармацевтическое применение
|
US6407244B1
(en)
|
2000-01-26 |
2002-06-18 |
Gemin X Biotechnologies Inc. |
Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
|
US20040082557A1
(en)
|
2001-01-26 |
2004-04-29 |
Wajszczuk Charles Paul |
Methods for treating estrogen-dependent disorders
|
US20030100605A1
(en)
|
2001-05-15 |
2003-05-29 |
Grupp Stephan A. |
Methods of treating cancer with angiogenesis inhibitors
|
JP4458514B2
(ja)
|
2002-07-18 |
2010-04-28 |
第一三共株式会社 |
高純度のエナミン類の製造方法
|
EP2385138A1
(en)
|
2002-07-31 |
2011-11-09 |
University of Southern California |
Polymorphisms for predicting disease and treatment outcome
|
US20050107350A1
(en)
|
2003-08-22 |
2005-05-19 |
Pharmacia Corporation |
Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
|
US20050187278A1
(en)
|
2003-08-28 |
2005-08-25 |
Pharmacia Corporation |
Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
|
WO2005020926A2
(en)
|
2003-08-28 |
2005-03-10 |
Pharmacia Corporation |
Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
|
WO2005048979A2
(en)
|
2003-10-06 |
2005-06-02 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition having casing with multiple micro tablets
|
US8614318B2
(en)
|
2003-11-13 |
2013-12-24 |
Abbvie Inc. |
Apoptosis promoters
|
EP1737471A4
(en)
|
2004-04-20 |
2010-08-25 |
Rnd Pharmaceuticals |
PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SILICON-SUBSTITUTED CYCLO-OXYGENASE-2 LIPOPHILIC DRUGS AND DERIVATIVES
|
JP2008501677A
(ja)
*
|
2004-06-04 |
2008-01-24 |
ファイザー・プロダクツ・インク |
異常な細胞増殖を治療する方法
|
PL1791565T3
(pl)
|
2004-09-23 |
2016-10-31 |
|
Modyfikowane cysteiną przeciwciała i koniugaty
|
US7608416B2
(en)
|
2004-12-07 |
2009-10-27 |
The Trustees Of The University Of Pennsylvania |
Targeting mPGES-1 as a treatment for inflammation which avoids cardiovascular risk
|
US7625911B2
(en)
|
2005-01-12 |
2009-12-01 |
Mai De Ltd. |
Amorphous form of erlotinib hydrochloride and its solid amorphous dispersion
|
US7378508B2
(en)
|
2007-01-22 |
2008-05-27 |
Optimer Pharmaceuticals, Inc. |
Polymorphic crystalline forms of tiacumicin B
|
US20070100148A1
(en)
|
2005-10-31 |
2007-05-03 |
Veerender Murki |
Process for preparing anastrozole
|
US7538230B2
(en)
|
2005-11-14 |
2009-05-26 |
Chemagis Ltd. |
Letrozole production process
|
US8143255B2
(en)
|
2005-11-16 |
2012-03-27 |
S*Bio Pte Ltd. |
Heteroalkyl linked pyrimidine derivatives
|
WO2008076949A2
(en)
*
|
2006-12-15 |
2008-06-26 |
Concert Pharmaceuticals Inc. |
Quinazoline derivatives and methods of treatment
|
JP5001027B2
(ja)
|
2007-03-02 |
2012-08-15 |
本田技研工業株式会社 |
自動二輪車のフェンダ支持構造
|
JP2010533205A
(ja)
|
2007-07-12 |
2010-10-21 |
トラガラ ファーマシューティカルズ,インク. |
癌、腫瘍、および腫瘍関連障害を治療するための方法および組成物
|
EP2205077A4
(en)
|
2007-09-24 |
2010-12-29 |
Tragara Pharmaceuticals Inc |
THERAPIES FOR THE TREATMENT OF CANCER BASED ON COMBINATIONS OF COX-2 INHIBITORS AND ANTI-HER2 (ERBB2) ANTIBODIES OR COMBINATIONS OF COX-2 INHIBITORS AND HER2 (ERBB2) RECEPTOR TYROSINE KINASE INHIBITORS
|